Literature DB >> 1673388

Gastrointestinal absorption of xenobiotics in physiologically based pharmacokinetic models. A two-compartment description.

D A Staats1, J W Fisher, R B Connolly.   

Abstract

Gastrointestinal (GI) absorption in physiologically based pharmacokinetic models is typically described as first-order transfer from one compartment directly into the liver. This approach appears to be adequate for water but not for oily vehicles. In this study, a two-compartment description of GI absorption was developed in which the chemical moved from the first compartment to the second (first-order rate constant KT) and was absorbed from both compartments (first-order rate constants KAS and KAD, respectively) into the liver. Rat blood time-course data sets for methylene chloride, chloroform, dichloroethane, and trichloroethylene after oral gavage in water or corn oil obtained from the literature were used for model validation. Optimization of the KAS, KAD, and KT values for each dosing solution allowed accurate simulation of each data set. In general, the KAS values were 3-4 times greater when water rather than corn oil vehicle was used. The KAD and KT values were similar for the two vehicles. By comparison, a one-compartment description resulted in a poor simulation of the oil gavage data. The two-compartment model rate constant values obtained by optimization of the rat blood time-course data set for trichloroethylene after oral gavage in water were used in the model to predict rat exhaled breath concentrations after oral gavage of trichloroethylene in water (data generated in this laboratory). Exhaled breath trichloroethylene concentrations compared favorably with model predictions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673388

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  10 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents.

Authors:  Susan Ritger Crowell; Shantu G Amin; Kim A Anderson; Gowdahalli Krishnegowda; Arun K Sharma; Jolen J Soelberg; David E Williams; Richard A Corley
Journal:  Toxicol Appl Pharmacol       Date:  2011-09-29       Impact factor: 4.219

3.  Tissue Distribution, Excretion and Pharmacokinetics of the Environmental Pollutant Dibenzo[def,p]chrysene in Mice.

Authors:  Yuan-Wan Sun; Karam El-Bayoumy; Cesar Aliaga; Alaa S Awad; Krishne Gowda; Shantu Amin; Kun-Ming Chen
Journal:  Chem Res Toxicol       Date:  2015-06-11       Impact factor: 3.739

4.  Impact of pregnancy on the pharmacokinetics of dibenzo[def,p]chrysene in mice.

Authors:  Susan Ritger Crowell; Arun K Sharma; Shantu Amin; Jolen J Soelberg; Natalie C Sadler; Aaron T Wright; William M Baird; David E Williams; Richard A Corley
Journal:  Toxicol Sci       Date:  2013-06-06       Impact factor: 4.849

5.  A physiological and system analysis hybrid pharmacokinetic model to characterize carbon tetrachloride blood concentrations following administration in different oral vehicles.

Authors:  J M Gallo; L L Cheung; H J Kim; J V Bruckner; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1993-10

6.  Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125.

Authors:  R Kawai; M Lemaire; J L Steimer; A Bruelisauer; W Niederberger; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1994-10

7.  Pharmacokinetics of Saquinavir Mesylate from Oral Self-Emulsifying Lipid-Based Delivery Systems.

Authors:  Thiago Caon; Jadel Muller Kratz; Gislaine Kuminek; Melina Heller; Gustavo Amadeu Micke; Bibiana Verlindo de Araujo; Letícia Scherer Koester; Cláudia Maria Oliveira Simões
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

Review 8.  Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.

Authors:  H J Clewell; P R Gentry; T R Covington; J M Gearhart
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 9.  Issues in the pharmacokinetics of trichloroethylene and its metabolites.

Authors:  Weihsueh A Chiu; Miles S Okino; John C Lipscomb; Marina V Evans
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

10.  PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2002-08-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.